candesartan and glucagon-like peptide 1

candesartan has been researched along with glucagon-like peptide 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mizuta, M; Nakazato, M; Noma, K; Saitoh, Y; Ueno, H; Wang, HW	1

Other Studies

1 other study(ies) available for candesartan and glucagon-like peptide 1

Article	Year
Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic β-cells. Metabolism: clinical and experimental, 2011, Volume: 60, Issue:8 Topics: Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Cell Line; Dose-Response Relationship, Drug; Female; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin Receptor Substrate Proteins; Insulin-Secreting Cells; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Tetrazoles	2011

Article

Year

Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic β-cells.

Metabolism: clinical and experimental, 2011, Volume: 60, Issue:8

Topics: Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Cell Line; Dose-Response Relationship, Drug; Female; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin Receptor Substrate Proteins; Insulin-Secreting Cells; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Tetrazoles

2011